Equity Management & Valuation, Ascenion GmbH
Anja has worked for Ascenion GmbH since September 2001. She has a PhD in biology and also holds an MBA. She is responsible for managing the equity of Ascenion’s spin-offs, for scientific and in particular economic evaluations of inventions and for promoting licenses of Intellectual Property Rights to the biotech industry and big pharma. Apart from analysing the scientific background of inventions, she also assesses the market potential of Intellectual Property. This ranges from general market reviews to detailed analysis, including net present value (NPV) calculations. She is a chairperson of the MGC-Foundation.
Anja is actively involved in supporting spin-offs from academic institutions and is a jury member of MBPW assessing entrepreneurial ideas and business plans and is coach and reviewer for the HTGF (High-Tech Gründerfonds). She regularly gives talks on assessment of IPR at national and international events like NGFNII, ASTP and UN/ECE-seminars and is an expert for the European Commission.
Before joining Ascenion, Anja worked at Klinikum Grosshadern, Munich and at Mount Sinai School of Medicine, New York in cancer research. She studied biology and did her PhD work at the Ludwig-Maximilians-University in Munich, focusing on immunology, microbiology and molecular biology and received her MBA from Cardiff University. Before going to university she was worked for Deutsche Bank AG.